Telbivudine/Torcitabine Idenix/Novartis |
| |
| Authors: | Hodge R Anthony Vere |
| |
| Affiliation: | Vere Hodge AntiVirals Ltd, Old Denshott, Leigh, Reigate, Surrey, RH2 8RD, UK. averehodge@aol.com |
| |
| Abstract: | Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential treatment of hepatitis B virus infection. Phase III trials of telbivudine were underway by August 2002 and phase I/II trials of the torcitabine prodrug, valtorcitabine, were ongoing in November 2003. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
